Tempest Therapeutics Total Liabilities

Tempest Therapeutics (TPST) currently reports a total liabilities of $11M as of June 2026. That compares with $15M in the prior-year period — down 27.1% year over year. Use the charts on this page to explore Tempest Therapeutics's total liabilities history and peer comparisons.

Tempest Therapeutics's total liabilities decreased from $15M to $11M — a 27.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tempest Therapeutics reported $11M in total liabilities as of June 2026. That compares with $15M in the prior-year period — down 27.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tempest Therapeutics, and consider following TPST for alerts when major investors trade the stock.

Tempest Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TPST with unrelated industries.